PCF at 30 – The New Global Public Square
Dear Friends, After completing my first full year leading the Prostate Cancer Foundation (PCF) community of patients, families, researchers, and clinicians, I’m delighted to share with you just how much has happened at PCF in 2022, as we also look ahead to 2023. As you may have seen, we have. Read More
12/09/2022
Research Update: PRESTO trial aims to help guide treatment for patients with rising PSA after surgery
Rising PSA after prostatectomy is common; as many as 40% of patients may experience biochemical recurrence within 10 years. Additional evidence-based guidance is needed about whom to treat, which therapies to use, and how long to treat. The PRESTO trial is collecting data to address this vital question. Results were. Read More
12/09/2022
Chicken Fried Quinoa
The holidays can bring more complicated cooking adventures and heavier meals than usual. Enjoying leisurely dinners with friends and family is a wonderful way to spend time together. But on your “off” nights, you may want something quick and healthy that you can toss in a pan and be done. Read More
12/09/2022
From the Prostate Cancer Research Desk: Clinical Trials of New Therapies
This update on prostate cancer research includes two clinical trials of new therapies presented at the European Society of Medical Oncology (ESMO) Congress 2022, held in Paris. Clinicians, researchers, industry partners, and others from across the globe gathered to share the latest developments in cancer research and treatment. Investigating a. Read More
TACTICAL Awards- Class of 2022
The PCF TACTICAL Award-Class of 2022 recipients are: Project Title: An Accelerated Platform using Lead-212 Targeted α-particle Therapy to Radically Improve Cancer Lethality of Prostate Cancer Theranostics using Novel Targets and Better Understanding of Resistance: the Cancer Lethality Lead Collaboration Principal Investigators: Michael Hofman, MBBS (Peter MacCallum Cancer Centre), Mohammad. Read More
11/17/2022
Winter Crunch Salad
Salad in November? Absolutely. Warm roasted vegetables bring health and comfort to dinner on a chilly evening, but it can also be refreshing to wake up your palate with a vibrant, crunchy salad. This one really pops with tart, bright flavors from cilantro, lime juice, and Granny Smith apple, and. Read More
11/17/2022
Gleason 3+3=6 is NOT “Not Cancer”
“Don’t worry about Gleason 3+3=6 (Grade Group 1)! It’s harmless! We shouldn’t even call it cancer! In fact, let’s call it IDLE (indolent lesion of epithelial origin)!” Many patients have heard reassurances like these, and yes, if you have to have prostate cancer, Gleason 6 is the best kind to. Read More
11/17/2022
For Gay and Bisexual Men: What You Need to Know About Treatment for Localized Prostate Cancer
If you are a gay or bisexual man and you have localized prostate cancer, there’s something you should know: the overwhelming majority of research on recovery, quality of life, and side effects of treatment for localized prostate cancer is based on heterosexual men. Confession: I have been writing about prostate. Read More
11/14/2022
Prostate Cancer and Eggs, Dairy, Supplements: Your Questions Answered (Part 1)
Dr. Stacey Kenfield, Associate Professor in the Departments of Urology and Epidemiology & Biostatistics at UCSF, was a recent guest on PCF’s monthly webinar series hosted by CEO Dr. Charles Ryan. She discussed her research on Prostate 8, a collection of lifestyle changes that have been shown to reduce a. Read More
Young Investigator Award – Class of 2022
The PCF Young Investigator Award-Class of 2022 recipients are: 2022 Todd Boehly - PCF Young Investigator Award Vipul Bhatia, PhD Fred Hutchinson Research Center Mentors: John K. Lee, MD, PhD, Peter Nelson, MD STEAP1 Directed Next-Generation Chimeric Antigen Receptor T Cell Therapies for Metastatic Castration Resistant Prostate Cancer (mCRPC) Description:. Read More